Paul Cremer
About
Paul Cremer is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Radiology, Nuclear Medicine and Imaging.
According to data from OpenAlex, Paul Cremer has authored 181 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 134 papers in Cardiology and Cardiovascular Medicine, 50 papers in Epidemiology and 46 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Paul Cremer's work include Pericarditis and Cardiac Tamponade (56 papers), Infective Endocarditis Diagnosis and Management (47 papers) and Cardiac Imaging and Diagnostics (44 papers). Paul Cremer is often cited by papers focused on Pericarditis and Cardiac Tamponade (56 papers), Infective Endocarditis Diagnosis and Management (47 papers) and Cardiac Imaging and Diagnostics (44 papers). Paul Cremer collaborates with scholars based in United States, Italy and Canada. Paul Cremer's co-authors include Wael A. Jaber, Allan L. Klein, Serge C. Harb, Steven E. Nissen, Massimo Imazio, Dermot Phelan, Kyle Mandsager, Tom Kai Ming Wang, Bo Xu and Antonio Abbate and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.
In The Last Decade
Paul Cremer
157 papers receiving 3.3k citations
Hit Papers
Peers
Paul Cremer
Matthew W. Martinez United States
Vassilios S. Vassiliou United Kingdom
Pankaj Garg United Kingdom
Chiara Lazzeri Italy
Ville Kytö Finland
Carol Mitchell United States
Lingzhong Meng United States
Kristina H. Haugaa Norway
James E. Ip United States
Michael Lichtenauer Austria
Citations per year, relative to Paul Cremer Paul Cremer (= 1×)
peers
Matthew W. Martinez
Countries citing papers authored by Paul Cremer
Since
Specialization
Citations
This map shows the geographic impact of Paul Cremer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Cremer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Cremer more than expected).
Fields of papers citing papers by Paul Cremer
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Paul Cremer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Cremer. The network helps show where Paul Cremer may publish in the future.
Co-authorship network of co-authors of Paul Cremer
This figure shows the co-authorship network connecting the top 25 collaborators of Paul Cremer. A scholar is included among the top collaborators of Paul Cremer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Cremer. Paul Cremer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Liga, Riccardo, Ronny R. Buechel, Andreas A. Giannopoulos, et al.. (2025). Patient centric performance and interpretation of SPECT and SPECT/CT myocardial perfusion imaging: a clinical consensus statement of the European Association of Cardiovascular Imaging of the ESC. PubMed. 3(1). qyaf043–qyaf043.
2.
Narang, Akhil, Maria Isabel Körber, Kai Friedrichs, et al.. (2025). Assessment of the GLIDE Score for Prediction of Mild Tricuspid Regurgitation following Tricuspid Transcatheter Edge-to-Edge Repair. JACC Advances. 4(2). 101523–101523.
3.
Brown, Kayla, Ke Xu, Rebecca T. Hahn, et al.. (2025). Impact of Coronary Artery Disease on Cardiovascular Outcomes Differs Between Men and Women With Severe Aortic Stenosis. Circulation Cardiovascular Interventions. 18(8). e014999–e014999.
4.
Budde, Ricardo P.J., Suhny Abbara, Hatem Alkadhi, et al.. (2025). Cardiac Computed Tomography for Prosthetic Heart Valve Assessment. Journal of the American College of Cardiology. 86(15). 1203–1230.
5.
Budde, Ricardo P.J., Suhny Abbara, Hatem Alkadhi, et al.. (2025). Cardiac Computed Tomography for Prosthetic Heart Valve Assessment. An Expert Consensus Document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Cardiology (ACC), the European Society of Cardiovascular Radiology (ESCR), the North American Society of Cardiovascular Imaging (NASCI), the Radiological Society of North America (RSNA), the Society for Cardiovascular Angiography & Interventions (SCAI), and Society of Thoracic Surgeons (STS)1,2. Radiology Cardiothoracic Imaging. 7(3). e250231–e250231.
6.
Cremer, Paul, et al.. (2024). Sex-Specific Prognosis of Left Ventricular Size and Function Following Repair of Degenerative Mitral Regurgitation. Journal of the American College of Cardiology. 83(2). 303–312.
7.
Abbate, Antonio, Benjamín Van Tassell, Vladimir Bogin, et al.. (2024). Interleukin-1 Blockade With RPH-104 (Goflikicept) in Patients With ST-Segment Elevation Myocardial Infarction: Secondary End Points From an International, Double-Blind, Randomized, Placebo-Controlled, Phase 2a Study. Journal of Cardiovascular Pharmacology. 84(6). 565–577.
8.
Imazio, Massimo, Allan L. Klein, Antonio Brucato, et al.. (2024). Sustained Pericarditis Recurrence Risk Reduction With Long‐Term Rilonacept. Journal of the American Heart Association. 13(6). e032516–e032516.
9.
Agrawal, Ankit, Beni Verma, David D. Y. Chen, et al.. (2024). Predicting Long-Term Clinical Outcomes of Patients With Recurrent Pericarditis. Journal of the American College of Cardiology. 84(13). 1193–1204.
10.
Chan, Nicholas, Pavan Bhat, Serge C. Harb, et al.. (2023). Negative Predictive Value and Prognostic Associations of Rb-82 PET/CT with Myocardial Blood Flow in CAV. JACC Heart Failure. 11(5). 555–565.
11.
Hutt, Erika, Tom Kai Ming Wang, Ziad Taimeh, et al.. (2023). Optimal left ventricular ejection fraction in risk stratification of patients with cardiac sarcoidosis. EP Europace. 25(9).
12.
Chawla, Sanchit, et al.. (2023). Glycemic patterns and impact of early hyperglycaemia in patients with cardiogenic shock on mechanical circulatory support. European Heart Journal Acute Cardiovascular Care. 12(5). 328–335.
13.
Hussain, Muzna, Eoin Donnellan, Trejeeve Martyn, et al.. (2022). Association Between Atrial Uptake on Cardiac Scintigraphy With Technetium-99m-Pyrophosphate Labeled Bone-Seeking Tracers and Atrial Fibrillation. Circulation Cardiovascular Imaging. 15(5). e013829–e013829.
14.
Hernández-Montfort, Jaime, Varinder K. Randhawa, Ziad Taimeh, et al.. (2022). Hemodynamic-based Assessment and Management of Cardiogenic Shock. SHILAP Revista de lepidopterología. 16. e05–e05.
15.
Vecchié, Alessandra, Marco Giuseppe Del Buono, Adolfo G Mauro, et al.. (2022). Advances in pharmacotherapy for acute and recurrent pericarditis. Expert Opinion on Pharmacotherapy. 23(6). 681–691.
16.
Desai, Milind Y., Anjali Owens, Jeffrey B. Geske, et al.. (2022). Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 Weeks. Circulation. 147(11). 850–863.
17.
Lin, David, Allan L. Klein, David Cella, et al.. (2021). Health-related quality of life in patients with recurrent pericarditis: results from a phase 2 study of rilonacept. BMC Cardiovascular Disorders. 21(1). 201–201.
18.
Klein, Allan L., et al.. (2021). US Database Study of Clinical Burden and Unmet Need in Recurrent Pericarditis. Journal of the American Heart Association. 10(15). e018950–e018950.
19.
Donnellan, Eoin, Oussama M. Wazni, Mohamed Kanj, et al.. (2019). Association between pre-ablation bariatric surgery and atrial fibrillation recurrence in morbidly obese patients undergoing atrial fibrillation ablation. EP Europace. 21(10). 1476–1483.
20.
Klein, Allan L., David Lin, Paul Cremer, et al.. (2019). Abstract 12851: Efficacy and Safety of Rilonacept in Recurrent Pericarditis: A Multicenter Phase 2 Clinical Trial. Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Matthew W. Martinez Breakdown of academic impact, for papers by Vassilios S. Vassiliou Breakdown of academic impact, for papers by Pankaj Garg Breakdown of academic impact, for papers by Chiara Lazzeri Breakdown of academic impact, for papers by Ville Kytö Breakdown of academic impact, for papers by Carol Mitchell Breakdown of academic impact, for papers by Lingzhong Meng Breakdown of academic impact, for papers by Kristina H. Haugaa Breakdown of academic impact, for papers by James E. Ip Breakdown of academic impact, for papers by Michael Lichtenauer